Why the study?
Does autonomic regulation therapy via vagus nerve stimulation maintain safety and efficacy at 12 months in patients with HFrEF?
Population
49 patients with chronic heart failure and reduced left ventricular ejection fraction, NYHA class II-III…
Comparison
Autonomic regulation therapy via vagus nerve… vs Left versus right cervical vagus nerve placement.
Design
Cohort, Randomized to left or right cervical vagus nerve placement
Follow-up
12 months total posttitration
Authors
Loading...
Supports sustained safety and efficacy of vagus nerve stimulation to 12 months in HFrEF; hypothesis-generating pending randomized trials.
Does autonomic regulation therapy via vagus nerve stimulation maintain safety and efficacy at 12 months in patients with HFrEF?
Chronic open-loop autonomic regulation therapy via vagus nerve stimulation appears feasible, safe, and maintains improvements in cardiac function and symptoms up to 12 months in patients with HFrEF.
Premchand et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: